TRITERPENE AMINE DERIVATIVES Read more about TRITERPENE AMINE DERIVATIVES New Zealand769842Filed on 2019-06-28
NANOPARTICLE TO TARGET CANCER Read more about NANOPARTICLE TO TARGET CANCER US Patent 11,696,922Filed on 2021-12-17
TARGETED CANCER THERAPY Read more about TARGETED CANCER THERAPY US Application 17/528,827Filed on 2021-11-17
HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR FLT3 AND USES THEREOF Read more about HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR FLT3 AND USES THEREOF US Application 17/570,248Filed on 2022-01-06
Denoising of Synamic Magnetic Resonance Spectroscopic Imaging Using Low Rank Approximations in the Kinetic Domain Read more about Denoising of Synamic Magnetic Resonance Spectroscopic Imaging Using Low Rank Approximations in the Kinetic Domain US Application 17/576,283Filed on 2022-01-14
CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 Read more about CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 US Application 17/608,832Filed on 2021-11-04
Fully Human Antibodies Targeting Human GPC2 For Therapeutics Development Read more about Fully Human Antibodies Targeting Human GPC2 For Therapeutics Development Canada3139507Filed on 2020-05-06
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION Hong Kong62022047561.5Filed on 2022-02-04
T CELLS HAVING ENHANCED ANTI-TUMOR ACTIVITY Read more about T CELLS HAVING ENHANCED ANTI-TUMOR ACTIVITY US Application 17/633,414Filed on 2022-02-07
Chimeric Antigen Receptors Targeting CD-19 Read more about Chimeric Antigen Receptors Targeting CD-19 Japan2021-215427Filed on 2021-12-29